PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Academic Neurology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, United Kingdom.\', \'Direct Commissioning, National Health Services Arden and Greater East Midlands Commissioning Support Unit, Leicester, United Kingdom.\', \'National Health Services England and National Health Services Improvement Midlands Region, Derby, United Kingdom.\', \'Neurology Department, St George\'s University Hospitals NHS Foundation Trust, London, United Kingdom.\', \'Department of Clinical Neuroscience, University of Cambridge, Cambridge, United Kingdom.\', \'School of Health and Social Care, University of Lincoln, Lincoln, United Kingdom.\', \'Academic Neurology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, United Kingdom. Electronic address: nikos.evangelou@nottingham.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-0348(21)00724-010.1016/j.msard.2021.103458
?:doi
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 34896876
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all